Skip to main content
. 2020 Mar 24;7(4):ofaa100. doi: 10.1093/ofid/ofaa100

Table 1.

Participant Baseline Demographics, Clinical, and CSF Findings by Disease Category

Characteristics Cryptococcal Meningitis TBM (Confirmed) TBM (Probable) Unknown Othera
N 198 40 22 88
Age, years 35 [29–42] 32 [28–36] 38 [30–48] 37 [30–44]
Women 79 (40%) 17 (43%) 11 (50%) 40 (45%)
HIV Factors
CD4+ T cells/μL 23 [8–70] 72 [41–111] 55 [22–186] 205 [45–340]
Currently on ART 91 (46%) 17 (43%) 8 (38%) 51 (58%)
Months on ARTb 2.3 [0.6–29.4] 2.2 [0.7–27.9] 1.5 [0.5–11.3] 6.9 [1.6–73.9]
Clinical
Fever 77 (52%) 34 (97%) 20 (91%) 46 (68%)
Headache 190 (98%) 34 (94%) 15 (68%) 61 (76%)
Duration of headache 14 [7–21] 14 [8–21] 14 [7–21] 14 [7–30]
Focal neurologic deficit 7 (4%) 15 (38%) 8 (36%) 21 (24%)
Wasting 81 (42%) 23 (58%) 13 (59%) 35 (41%)
Glasgow come score <15 70 (35%) 36 (92%) 19 (86%) 45 (52%)
Seizure 41 (30%) 11 (38%) 4 (21%) 23 (38%)
Weight, kg 52 [45–60] 55 [45–58] 53 [50–60] 50 [50–59]
Cough 56 (39%) 25 (74%) 10 (53%) 39 (61%)
Night sweatsc 31 (25%) 22 (85%) 13 (72%) 24 (44%)
Baseline CSF Results
Opening pressure, cm H2O 23 [14–32] 19 [10–29] 15 [10–24] 18 [12–23]
Opening pressure <20 cm H2O 66 (38%) 16 (52%) 10 (67%) 40 (62%)
Total WBC count cells μL <5 [<5–50] 30 [<5–220] <5 [<5–200] <5 [<5–30]
Total WBC count <5 μL 117 (60%) 17 (45%) 11 (52%) 61 (71%)
CSF protein, mg/dL 69 [36–100] 128 [61–200] 88 [31–151] 68 [28–111]
CSF WBC <5 μL and protein <45 mg/dL 51 (28%) 5 (15%) 4 (20%) 26 (36%)

Abbreviations: ART, antiretroviral therapy; CSF, cerebrospinal fluid; HIV, human immunodeficiency virus; IQR, interquartile range; TBM, tuberculous meningitis; WBC, white blood cells.

NOTE: Data are n (%) or median [IQR].

aIncludes possible and nontuberculous meningitis diagnoses.

bAmong those on ART at diagnosis.

cData on night sweats were only available for 122 of cryptococcosis, 26 definite TB meningitis, 18 probable TB meningitis, and 54 other.